Kayne Anderson Rudnick Investment Management
GMED icon

Kayne Anderson Rudnick Investment Management’s Globus Medical GMED Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338M Buy
+4,279,730
New +$364M 1.05% 29
2024
Q1 		– Sell
-7
Closed -$373 – 971
2023
Q4 		$373 Hold
7
– – ﹤0.01% 903
2023
Q3 		$348 Sell
7
-461
-99% -$25.8K ﹤0.01% 816
2023
Q2 		$27.9K Sell
468
-1,118
-70% -$63.7K ﹤0.01% 536
2023
Q1 		$89.8K Sell
1,586
-6,183,580
-100% -$397M ﹤0.01% 457
2022
Q4 		$459M Buy
6,185,166
+1,629,455
+36% +$111M 1.43% 14
2022
Q3 		$271M Sell
4,555,711
-7,019
-0.2% -$423K 0.9% 37
2022
Q2 		$256M Buy
4,562,730
+2,542,264
+126% +$167M 0.81% 47
2022
Q1 		$149M Buy
2,020,466
+485,551
+32% +$33.8M 0.4% 80
2021
Q4 		$111M Sell
1,534,915
-12,690
-0.8% -$921K 0.26% 108
2021
Q3 		$119M Buy
1,547,605
+278,833
+22% +$22.4M 0.29% 100
2021
Q2 		$98.4M Buy
1,268,772
+249,884
+25% +$17.8M 0.24% 106
2021
Q1 		$62.8M Buy
1,018,888
+71,683
+8% +$4.54M 0.17% 126
2020
Q4 		$61.8M Buy
947,205
+61,370
+7% +$3.53M 0.18% 125
2020
Q3 		$43.9M Buy
885,835
+80,533
+10% +$4.15M 0.16% 128
2020
Q2 		$37.8M Buy
805,302
+114,287
+17% +$5.51M 0.16% 125
2020
Q1 		$29.4M Buy
691,015
+38,082
+6% +$1.88M 0.17% 114
2019
Q4 		$38.4M Buy
652,933
+65,741
+11% +$3.57M 0.19% 109
2019
Q3 		$30M Buy
587,192
+34,031
+6% +$1.62M 0.16% 112
2019
Q2 		$23.4M Buy
553,161
+71,718
+15% +$3.11M 0.12% 123
2019
Q1 		$23.8M Buy
481,443
+55,332
+13% +$2.5M 0.14% 116
2018
Q4 		$18.4M Buy
426,111
+86,776
+26% +$4.33M 0.13% 117
2018
Q3 		$19.3M Buy
339,335
+53,957
+19% +$2.84M 0.11% 133
2018
Q2 		$14.4M Buy
285,378
+48,624
+21% +$2.54M 0.09% 146
2018
Q1 		$11.8M Sell
236,754
-17,239
-7% -$810K 0.09% 159
2017
Q4 		$10.4M Buy
253,993
+4,585
+2% +$161K 0.08% 174
2017
Q3 		$7.41M Buy
249,408
+7,487
+3% +$229K 0.07% 181
2017
Q2 		$8.02M Buy
241,921
+20,910
+9% +$657K 0.08% 182
2017
Q1 		$6.55M Buy
221,011
+41,284
+23% +$1.13M 0.07% 184
2016
Q4 		$4.46M Buy
179,727
+80,362
+81% +$1.83M 0.05% 202
2016
Q3 		$2.24M Buy
99,365
+8,569
+9% +$201K 0.03% 239
2016
Q2 		$2.16M Buy
90,796
+16,082
+22% +$386K 0.03% 228
2016
Q1 		$1.77M Buy
74,714
+35,153
+89% +$859K 0.03% 236
2015
Q4 		$1.1M Buy
+39,561
New +$993K 0.02% 265

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's GMED Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management opened a new position in Globus Medical (GMED) in Q2 2026: 4,279,730 shares worth $338M. The stake represents 1.05% of the portfolio and ranks #29 among its holdings. This is a return to the name: Kayne Anderson Rudnick Investment Management previously reported a position in GMED as recently as Q4 2023.

Kayne Anderson Rudnick Investment Management first reported a position in GMED in Q4 2015 and has held it in 34 quarters since. The position peaked at $459M in Q4 2022. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 4,279,730 shares of Globus Medical worth $338M as of Q2 2026.
  • Globus Medical was a new Kayne Anderson Rudnick Investment Management position in Q2 2026.
  • Globus Medical made up 1.05% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #29 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Globus Medical in Q4 2015 and has held it in 34 quarters since.
  • Kayne Anderson Rudnick Investment Management's Globus Medical position peaked at $459M in Q4 2022.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.